Saturday, February 2, 2013


As Nurse Lay Dying, Offering Herself as Instruction in Caring

Ilana Panich-Linsman for The New York Times
A Lesson in Dying: With less than two months to live, Martha Keochareon teaches students about cancer and dying.
SOUTH HADLEY, Mass. — It was early November when Martha Keochareon called the nursing school at Holyoke Community College, her alma mater. She had a proposal, which she laid out in a voice mail message.
Multimedia
Ilana Panich-Linsman for The New York Times
Roy Christensen, a cousin of Ms. Keochareon’s, helped care for her.More Photos »

Readers’ Comments

Readers shared their thoughts on this article.
“I have cancer,” she said after introducing herself, “and I’m wondering if you’ll need somebody to do a case study on, a hospice patient.”
Perhaps some nursing students “just want to feel what a tumor feels like,” she went on. Or they could learn something about hospice care, which aims to help terminally ill people die comfortably at home.
“Maybe you’ll have some ambitious student that wants to do a project,” Ms. Keochareon (pronounced CATCH-uron) said after leaving her phone number. “Thank you. Bye.”
Kelly Keane, a counselor at the college who received the message, was instantly intrigued. Holyoke’s nursing students, like most, learn about cancer from textbooks. They get some experience with acutely ill patients during a rotation on the medical-surgical floor of a hospital. They practice their skills in the college’s simulation lab on sophisticated mannequins that can “die” of cancer, heart attacks and other ailments. But Ms. Keochareon, 59, a 1993 graduate of Holyoke’s nursing program, was offering students something rare: an opportunity not only to examine her, but also to ask anything they wanted about her experience with cancer and dying.
“She is allowing us into something we wouldn’t ever be privy to,” Ms. Keane said.
So it was that a few weeks later, two first-year nursing students, Cindy Santiago, 26, and Michelle Elliot, 52, arrived at Ms. Keochareon’s tiny house, a few miles from the college. She was bedbound, cared for by a loyal band of relatives, hospice nurses and aides. Both students were anxious.
“Sit on my bed and talk to me,” Ms. Keochareon said. The students hesitated, saying they had been taught not to do that, to prevent transmission of germs. What they knew of nursing in hospitals — “I’m here to take your vitals, give you your medicine, O.K., bye,” as Ms. Santiago put it — was different, after all.
They had come with a list of questions. Ms. Keochareon was suffering from pancreatic cancer, and they had researched the disease ahead of time. They were particularly curious about why she had survived for so long. She had lived with her illness for more than six years — an extraordinary span for pancreatic cancer, which often kills within months after diagnosis.
Why, the students asked, had she managed to keep eating and keep on weight? What was she taking for the pain? How long had it taken for doctors to give her a diagnosis?
“They ask good questions,” Ms. Keochareon said one morning, her lips stained red from the liquid oxycodone she was sipping frequently between doses of other drugs. “I forget half the stuff I learned as a nurse, but I remember everything about pancreatic cancer. Because I’m living it.”
For Ms. Keochareon, this was a chance to teach something about the profession she had found late and embraced — she became a nurse at 40, after raising her daughter and working for years on a factory floor.
“When I was a nurse, it seemed like most of the other nurses were never too happy having a student to teach,” she said, lying in her bedroom lined with pictures of relatives, friends, and herself in healthier times. “I loved it.”
A Last Project
Now, her disease had left her passing the days watching Animal Planet, reading a book about heaven and calling friends — so much that her cordless phone never left her side. She also was planning meticulously for her death, down to the green wool cardigan and embroidered shirt she would be buried in. But Ms. Keochareon wanted more as she prepared to die. The project she envisioned would be not just for students, but also for her — a way to squeeze one more chapter out of life.
Spending time with the dying is not fundamental to nurse training, partly because there are not enough clinical settings to provide the experience. The End-of-Life Nursing Education Consortium, a project of the American Association of Colleges of Nursing, has provided training in palliative care to some 15,000 nurses and nursing instructors around the nation since 2000, focusing not just on pain management but also on how to help terminally ill patients and their families prepare for death.
In addition, some students do rotations with hospice nurses, said Pam Malloy, the project’s director. But Ms. Malloy said that nursing schools still do not focus on end-of-life care nearly as much as they should. “We live in a death-denying society, and that includes nursing,” she said. “People have begun to understand it’s important, but we’re nowhere where we need to be at this point.”
Multimedia

Readers’ Comments

Readers shared their thoughts on this article.
In their conversations with Ms. Keochareon, the students learned that her symptoms had included a burning sensation after eating, for which doctors prescribed an acid blocker. Then came wrenching abdominal pain, which she said doctors dismissed as psychosomatic. She also developed diabetes, another potential sign of pancreatic cancer, and itchiness, possibly from blocked bile ducts.
In 2006, after she had felt sick for several years, a doctor finally ordered a CT scan, and the cancer was diagnosed. Ms. Keochareon was 53 and working at a hospital in Charleston, S.C. She was told that she would probably die within a year or two.
Ms. Santiago and Ms. Elliot were outraged on her behalf. But they were surprised, they said, to learn that instead of anger or shock, the first emotion that Ms. Keochareon felt after her diagnosis was relief because she finally knew what was wrong with her.
The best advice she could give future nurses, Ms. Keochareon said in her reedy voice, was “to just dig a little deeper — you know?”
Ms. Keochareon — who had several unhappy marriages before finding her current husband, Joe — also offered some personal advice. “Don’t yell at each other unless the house is on fire,” she told the students.
Perhaps more than anything, the students were learning about the challenge of managing late-stage cancer pain in a patient who had outlived her prognosis. Ms. Keochareon’s cancer had spread, and there were tumors in her bones and around her throat. By early December, the pain had grown unbearable; Ms. Keochareon was hospitalized for nearly a week while doctors assessed how to control it.
‘Let the Patient Talk’
At her request, the students kept visiting. The sessions provided a brief respite for Ms. Keochareon’s caretakers, including Roy Christensen, a cousin who moved back from Texas last year to help, and Peggy Casey, her favorite aunt. Seeing their exhaustion, the students learned another lesson: “The patient isn’t Martha per se,” Ms. Keane said, “it’s the entire family.”
At Ms. Keane’s urging, the students eventually stopped asking questions and practiced what she called “therapeutic communication” instead.
“The way we’ve learned in school, and haven’t applied enough, is just saying, ‘I’m glad to be with you; you must be frustrated; you look uncomfortable,'” Ms. Keane said. “And let the patient just talk and talk and talk, and see where they’re at.”
On a bright day shortly before Christmas, Ms. Keochareon had less to say than usual as Ms. Santiago perched on her bed.
“You look good,” Ms. Santiago said softly after they had chatted for a bit. Ms. Keochareon was clearly in pain; she mustered a brief smile and closed her eyes.
“I’m ready to go,” Ms. Keochareon told her, opening her eyes again.
Ms. Santiago paused. “Aw,” she said, patting Ms. Keochareon’s hand. “Well...”
“Don’t feel bad,” Ms. Keochareon added.
“I know,” Ms. Santiago said, shaking her look of concern into a smile. “I know.”
She wept after leaving the room. Her father has prostate cancer that has spread, she said; Ms. Keochareon’s declaration had left her thinking about him.
“I kind of wanted to break down,” she said. “I know I’m going to get there with my dad eventually.”
Ms. Santiago said she was afraid of death. Ms. Elliot, having seen it in her job at a local hospital, was less troubled by it. She is a licensed practical nurse who is pursuing a registered nurse degree to advance her career. Still, Ms. Elliot said that when her 81-year-old mother recently asked if she would accompany her to a funeral home to “pick stuff out and get everything ready,” she recoiled.
Multimedia

Readers’ Comments

Readers shared their thoughts on this article.
The new drugs that doctors had prescribed during Ms. Keochareon’s hospital stay failed to keep the pain at bay. She was trying another combination when Ms. Santiago visited again, shortly before Christmas, but with little relief. Ms. Santiago watched, arms tightly crossed, as Ms. Keochareon grimaced and moaned.
“In school they always teach us that pain management is the biggest thing — like, you know, we have to treat the pain,” Ms. Santiago said. “With her it’s like, how do you treat it? Like, you’ve tried everything. What else is there to try?”
She rubbed an anesthetic gel on Ms. Keochareon’s back and, with Ms. Keane’s help, tried to position her hospital bed to be more comfortable. Sunlight streamed through the window into the small, warm room; birds flitted around a feeder just outside. Ms. Keochareon briefly felt better and wanted Ms. Santiago to see her portfolio: a binder that contained her résumé, nursing licenses and letters of recommendation.
Learning from books was good, she said; learning from patients was better.
“When you look back,” Ms. Keochareon said, “you associate a certain person with a certain diagnosis.”
Ms. Santiago planned to return two days later. But Ms. Keochareon seemed to be saying goodbye.
“I’m sorry I went downhill so fast,” she said. “I thought I could teach more.”
Running Out of Time
Later that afternoon, Mr. Christensen, her cousin, called with an update. Ms. Keochareon had asked for an intravenous sedative that would make her sleep, delivering her from the mounting pain. That morning’s visit, it turned out, had been the last.
Ms. Elliot, who had planned to visit Ms. Keochareon after her shift that day, regretted not having asked more about how she felt about death.
“She already seemed to be at that spot where she had that inner peace about it,” Ms. Elliot said that evening. “You want to ask them the questions: So what does it feel like to be dying? Do you know something we don’t know?”
Ms. Keochareon died nine days later, in the evening on Dec. 29. Mr. Christensen had asked her to wait for snow; nearly six inches fell that night, the first of the season. Only her husband was there for her death — a consequence of the weather, but perhaps also part of her plan, Mr. Christensen said.
At the funeral, Ms. Keochareon’s sister Ruth Woodard spoke in her eulogy about “just what prompted Martha to offer her situation up as a teaching tool.” Ms. Keochareon deeply wanted nurses to understand her illness from the patient’s perspective, she said. But that was not all.
“I notice that every time that Martha gave of herself she received far more,” Ms. Woodard said. “In fact, she received a few moments of less pain and I suspect that she received life itself — a few more hours, even days, with purpose.”
When the new semester starts this month, Ms. Santiago and Ms. Elliot will return to more conventional coursework: a pharmacology class, for example, and rotations in maternity and acute care. But they will also present to their classmates what they learned in the little house in South Hadley. Ms. Santiago said she would remember Ms. Keochareon “until the day that I die” — especially her resolve.
“Who in her situation, to be like that, would call up and say, ‘Hey, I want to teach a student about my cancer?'” she said.

The Stages of Breast Cancer & the Importance of Early Detection

Nurse Assisting Patient Undergoing Mammogram
One of the best ways for women over 40 to detect breast cancer is an annual mammogram. Photo: iStockphoto

Until there is a cure for breast cancer, early detection practices likemammogramsclinical breast exams, and breast self-exams remain some of the most important ways to catch breast cancer early and increase survival rates. Tumor size upon detection, and therefore which cancer stage you are classified in, greatly effects prognosis.
According to the American Cancer Society, the 5-year survival rates decline quickly as breast cancer proceeds to the next stage:
  • Stage 0 – 93% 5-year survival rate
  • Stage I — 88% 5-year survival rate
  • Stage IIA — 81% 5-year survival rate
  • Stage IIB — 74% 5-year survival rate
  • Stage IIIA — 67% 5-year survival rate
  • Stage IIIB — 41% 5-year survival rate
  • Stage IIIC — 49% 5-year survival rate
  • Stage IV — 15% 5-year survival rate

Stage 0 Breast Cancer

Breast cancer stages start at 0, meaning the abnormal cancerous cells are still within the original site of the breast where they started. This means they are non-invasive.

Stage I Breast Cancer

Stage I occurs when the cancer cells break through the original site and invade surrounding tissue. At this stage, the tumor is just under or at 2 cm (.787 inches). The cancer is still within the boundaries of the breast. Stage I contains two subcategories.
  • Stage 1A: there is no lymph node involvement.
  • Stage 1B: there is micrometastases (minute spreading out) in 1 to 3 lymph nodes.
Read the story of a 26 year old health teacher who got her Stage I breast cancer diagnosed as a result of the Maurer Foundation breast health education programs.

Stage II Breast Cancer

Stage II also has two subcategories.
  • Stage IIA: the tumor is more than 2 cm but smaller than 5 cm (1.96 inches) with lymph node involvement.
  • Stage IIB: the tumor is larger than 2 cm, but without lymph node involvement or larger than 5 cm but not attached to the chest wall and still without lymph node involvement.
When a tumor is discovered between stages I and II, the chances for a successful treatment is at its highest, as it is still contained locally.

Stage III Breast Cancer

Stage III has three subcategories.
  • Stage IIIA: the tumor is less than 5 cm, spread to 5-9 lymph nodes but has not spread to distant sites.
  • Stage IIIB: the tumor has grown into the chest wall or skin, but without lymph node involvement or up to 9 axillary lymph nodes.
  • Stage IIIC: the tumor can be any size, spread to 10 or more lymph nodes in areas such as under the clavicle, above the clavicle, enlarged the mammary lymph nodes.
At this level the cancer cells are beginning to reach out beyond the breast. Some lymph nodes have been invaded; the tumor may or may not have attached itself outside the breast.

Stage IV Breast Cancer

Stage IV is the advanced stage where cancer has spread beyond the breast and its adjacent lymph nodes to other organs of the body that may include the brain, lungs or liver. This is also called metastatic cancer. If cancer reoccurs it often is a stage IV cancer.

Early Detection is Key To Surviving Breast Cancer

If you are over 40, get a yearly mammogram. A recent Swedish Cancer Institute study revealed that women between the ages of 40–49 who’ve had yearly mammograms and subsequent breast cancer diagnosis fare better than those that don’t. All women 18 and over should do a monthly breast self-exam and get an annual clinical breast exam. All lumps are not breast cancer, but asthis video points out, you shouldn’t ignore suspicious lumps. In the meantime, look at your lifestyle and do what you can to remove any risk factors you may have. Your health is in your hands.

Save A Life & Give To The Maurer Foundation

With your tax-deductible donation, we can continue to provide life-saving breast health education programs to high schools, colleges, and businesses. Our Educational Outreach Program depends on your financial support to bring this invaluable program to more people.
Knowledge is empowering and this program can make a real difference in the health and wellness of our community.

Have a Health Question? Ask Well


Have a Health Question? Ask Well

Karsten Moran, Aaron Houston and Gordon Welters for The New York Times, Brian Snyder, via Reuters
  • FACEBOOK
  • TWITTER
  • GOOGLE+
  • SAVE
  • E-MAIL
  • SHARE
  • PRINT
The Well section of The New York Times is starting a new online featured called Ask Well. If you have a question about fitness, nutrition, illness or family health, the staff of The New York Times Health section is ready to help you find the answer.

Tara Parker-Pope speaks about Ask Well.

All questions submitted to Ask Well will be reviewed by the health staff. We’ll post selected questions and let readers vote on those they would most like to see answered. You can ask a question, vote for your favorites and read answered questions on the Ask Well Questions Page.
While Ask Well is not a source for personal medical advice (only your doctor can give you that), we can offer readers health information from the experts and guide you to various resources to help you make informed decisions. So let’s get started. Tell us what’s on your mind, and Ask Well will provide the answers.
http://well.blogs.nytimes.com/2013/01/22/have-a-health-question-askwell/

Five Questions to Ask A Cancer Patient

by Michael Buller
Whenever I’ve met people with cancer, I’ve been at a loss for what to say and which questions to ask.
Now, as a cancer patient, I realize the irony.
Looking back, whatever I said ranged from ignorant to unhelpful. Or, I would just say nothing. I would talk about anything and everything else, but not about the cancer, being fully aware of the elephant in the room. 
But here’s the thing: the elephant’s not in the room. At least not for the cancer patient; not all the time. To let the topic of conversation be the elephant is to let the disease define the person. And it doesn’t. 
Ever.
So not discussing the topic is always a completely acceptable option. But if you feel compelled by compassion, concern, or curiosity (and assuming your friend is open to talking) here are a few good questions to ask. I wish I had been able to think of any of these when I was on the asking side. (For some good tips about what to say to someone who’s been just diagnosed, read this post.)
  1. How are you? Seems simple enough. But it’s better than: are you okay? Because most cancer patients aren’t okay, by definition. They have cancer. “Are you okay“ asks for a yes or no answer and it’s just not simple.
  2. What type of cancer is it? This beats the alternative that I’ve heard asked: “Is it the good kind of cancer?” There are different types of cancer to be sure — and all have different outcomes — so it’s important to know what cancer type your friend may be facing. But there is no good kind of cancer.
  3. How’s Stacy? This only works if your friend has a significant other named Stacy. But a cancer diagnosis places a huge burden on spouses/significant others; they’re often the unforgotten partners who bear the brunt of logistical challenges, not to mention the difficult emotional challenges. It’s always good to ask this question. If your friend’s significant other is not named Stacy, improvise.
  4. Is there anything I can do? 99 times out of 100, the answer will be no. But it lends great support just to ask the question. One of these times, someone will say yes.
  5. Want to grab a beer?  Or coffee. Or Del’s Lemonade. Or a fruit smoothie. Boredom is anxiety’s playing partner. Just staying busy, I find, offers its own benefit in its ability to keep one from diving too deeply into the often overwhelming overload of information overload; but a beverage and the company of a friend makes it even more valuable.
    As I said, these questions and many others have been asked of me. Even more numerous have been the messages of support, prayer, good vibes, positive juju, you name it. All of it – every last well-meaning word is appreciatively received.
Michael Buller is director of Editorial and Creative Services at Dana-Farber, and currently a patient. 

Breast cancer caught in the act of spreading


NATURE | NEWS

Breast cancer caught in the act of spreading

Characteristics of wandering tumour cells support a leading theory of metastasis.
Some of these circulating cells from a breast cancer patient have transitioned from their original cell type (epithelial, green) to a type that enables the disease to spread into metastases (mesenchymal, red).
IMAGE COURTESY OF MIN YU
An analysis of breast cancer cells captured as they escape from primary tumours has provided the best clinical evidence to date in favour of a popular theory of cancer metastasis.
The work, published this week in Science1, also unveils an improved method for plucking tumour cells from blood, a technique that may one day allow physicians and researchers to track the spread of cancer without resorting to invasive biopsies.
“It’s very exciting,” says Caroline Dive, a Cancer Research UK researcher at the University of Manchester. “It’s paving the way for an explosion of studies looking at these circulating tumour cells.”
Current cancer treatments typically target tumour growth, but it is metastasis — the spread of the cells to other tissues — that most often proves fatal. Before drug developers can produce therapies that halt the spread of cancer, however, they first need to understand how cells break free from a tumour, enter the bloodstream and colonize new tissue.

A long and winding road

How cancers cells make that journey has long puzzled researchers: the cells that make up cancers in epithelial tissue, such as the surface cells of the lung and breast, generally prefer to stick together and are not suited for a rough-and-tumble trip through the bloodstream. One theory holds that metastasizing tumour cells activate pathways that are normally reserved for ‘mesenchymal’ cells, which move around in developing embryos2. This has been termed the epithelial–mesenchymal transition, or EMT, and some companies have been hard at work developing drugs that target this switch.
But most of evidence supporting a role for the EMT in cancer spread has come from animal models. And analyses of tumour cells circulating in the blood has been limited because the techniques tend to pick up only epithelial cells. “It was pioneering technology, but we’ve always been worried that if EMT was happening, we’d miss the mesenchymal tumour cells this way,” says Dive.
Daniel Haber and Shyamala Maheswaran, both at the Massachusetts General Hospital Cancer Center in Boston, and their colleagues, therefore developed a new suite of markers to identify tumour cells circulating in the blood. They then tracked these cells, and characterized their gene expression, in 11 people undergoing chemotherapy for breast cancer.

New targets

The team found that when tumours responded to treatment, the proportion of circulating tumour cells harbouring mesenchymal features began to drop. Failure of therapy was followed by resurgence of mesenchymal tumour cells.
The team now plans to repeat the study in more patients and tumour types, says Haber. If the results hold up, they could provide drug developers with a list of new targets, says Klaus Pantel, a cancer researcher at the University Medical Centre Hamburg-Eppendorf in Germany.  
Pantel also notes that many of the circulating tumour cells had features of both mesenchymal and epithelial cells. That means the hunt may have to be re-focussed on an intermediate cell type, he says. “The cells that have gone all the way into a mesenchymal state may not be the bad guys after all."
Nature
 
doi:10.1038/nature.2013.12342
http://www.nature.com/news/breast-cancer-caught-in-the-act-of-spreading-1.12342

Friday, February 1, 2013


Getting married after cancer: Guilt is part of the diagnosis

| Comments (0)
getting_married_after_cancer_leukemia_patient_deals_with_guilt.JPGBy Justin Ozuna

Before proposing to Katie, I couldn't stop thinking about how the proposal would align with my cancer diagnosis and the uncertainty of my future.

Katie and I had been dating long-distance for two-and-a-half years while she attended graduate school in San Antonio.

Even though I was about to start a clinical trial forchronic myeloid leukemia, I was excited to ask Katie to marry me.

On January 14, 2012, amidst tears of joy, I clumsily stumbled through the reading of a letter that I had written. On the final page was the question, "Will you marry me?"

She said yes. 
Promises I couldn't make
Despite our excitement, however, I still struggled with feelings of guilt. Unlike most guys my age, I couldn't promise Katie the illusion of a comfortable and secure life.

I couldn't promise that we'd avoid adversity or that I'd be by her side on my 90th birthday. I could only promise that I'd do my best to hold her hand as we navigated through my often uncertain reality.

I spent the first part of my diagnosis pushing those feelings aside, never acknowledging that my situation was different from those of my peers.

Guilt is easy to ignore when cancer doesn't directly affect the lives of those intimately connected to you. That's why it's easy to push people away, to not let anyone get close to you, to give in to the temptation to isolate yourself from the world.

Guilt is always best served in isolation.

Although I knew Katie was emotionally invested in our relationship, the significance of an engagement and eventual marriage meant that every result from every piece of bone marrow taken from my body moving forward would be reflected in every tear of sadness or joy that falls down her cheek. In an irrational way, I feel responsible for that.

When I sought the engagement blessing of Katie's father, I did my best to acknowledge this awareness and assure him that I'd honor his little girl in a way that goes beyond life and all of its misfortune.

Even though I've overcome so much hardship at such a young age, it's sometimes difficult not to feel inadequate. It was all I could do to assure us both that I'd never give up our happiness for an illness I couldn't control.

Harsh realities of cancer
Soon after our engagement, I began a clinical trial at MD Anderson. I didn't think much about how the trial could impact our new life because I'd never before experienced significant side effects from my medications.

However, I quickly learned that I'd underestimated the potential consequences of physical adversity.

The trial failed. Soon after, we met with a stem cell transplant doctor to discuss the a bone marrow transplant. This wasn't how I envisioned everything would turn out.

Welcome to the world of cancer.

As rewarding as it was to know that I would spend the rest of my life with my best friend, I felt guilty for not knowing how long the rest of my life would be.

The thought of introducing Katie to unfamiliar emotions that no young adult should be asked to experience made me feel selfish.

In the same way that cancer corrupts the production of cells, the mind is constantly faced with deception. It's often difficult to distinguish between false feelings and reality.

"Is this my fault?" I often asked myself.

When treatment after a cancer diagnosis goes well, we're encouraged to live a normal life.

But when that pursuit is disrupted by a questionable blood test or scan, it's as if the normal life you tried to live was merely the fishnet used to expose a new set of people to the harsh realities of the cancer world. It's no wonder that some people never try to live a normal life at all.

Our new normal
Katie and I often talk to each other about our feelings and try to process what we're each going through, and that goes a long way. But guilt is a tricky emotion that is often hard to reach.

We have to stay on top of it and constantly reassure each other that negative feelings are distortions of a deeper love and security. Throughout my seven years battling leukemia, I learned that guilt is a part of the diagnosis.

Katie and I will get married in October of this year. I've reached a complete molecular remission, and I know, for now, that the prognosis for a normal, healthy life is somewhat good. But it's sometimes difficult to know that landmines exist in our household.

This is our new normal. Every day that I wake up, I realize I am the luckiest person in the world, first because I have my health, and second, because Katie chose to be with me when she didn't have to.

Justin Ozuna lives in Dallas and was diagnosed with chronic myeloid leukemia in January 2006. He is a Texas state representative and Dallas/Fort Worth facilitator for the National CML Society and a patient at MD Anderson. His mission is to capture the ups and downs of a young adult living with cancer and to serve people through humor, encouragement, hope and adversity at his blog, theozunaverse.com.